Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
about
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@en
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@nl
type
label
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@en
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@nl
prefLabel
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@en
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@nl
P2093
P1476
Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.
@en
P2093
Alberto J Martinez
Arni Steingrimsson
Carlos Oliveira
Harriet Kluger
Heinrich Roder
Jeffrey Weber
Joanna Roder
Julia Grigorieva
Kevin Sayers
Krista Meyer
P2888
P304
P356
10.1186/2051-1426-3-S2-P103
P433
P577
2015-11-04T00:00:00Z
P5875
P6179
1022948025